Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome

[1]  D. Tegunov,et al.  Architecture of the RNA polymerase II-Paf1C-TFIIS transcription elongation complex , 2017, Nature Communications.

[2]  B. Harding,et al.  Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome , 2017, Oncogene.

[3]  Lin Wang,et al.  CDC73 gene mutations in sporadic ossifying fibroma of the jaws , 2016, Diagnostic Pathology.

[4]  A. Aiba,et al.  Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt/Hedgehog/Notch pathways , 2016, Nature Communications.

[5]  G. Palù,et al.  Characterization of a New CDC73 Missense Mutation that Impairs Parafibromin Expression and Nucleolar Localization , 2014, PloS one.

[6]  A. Gill Understanding the Genetic Basis of Parathyroid Carcinoma , 2014, Endocrine Pathology.

[7]  M. Copetti,et al.  Identification and Functional Characterization of Three NoLS (Nucleolar Localisation Signals) Mutations of the CDC73 Gene , 2013, PloS one.

[8]  M. Rugge,et al.  CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer , 2013, Endocrine connections.

[9]  Hao Zhou,et al.  Structural insights into Paf1 complex assembly and histone binding , 2013, Nucleic acids research.

[10]  P. Chanson,et al.  Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. , 2013, The Journal of clinical endocrinology and metabolism.

[11]  Brett N. Tomson,et al.  The many roles of the conserved eukaryotic Paf1 complex in regulating transcription, histone modifications, and disease states. , 2013, Biochimica et biophysica acta.

[12]  M. Teng,et al.  Crystallographic analysis of the conserved C-terminal domain of transcription factor Cdc73 from Saccharomyces cerevisiae reveals a GTPase-like fold. , 2012, Acta crystallographica. Section D, Biological crystallography.

[13]  Christopher P. Davis,et al.  Cdc73 Subunit of Paf1 Complex Contains C-terminal Ras-like Domain That Promotes Association of Paf1 Complex with Chromatin* , 2012, The Journal of Biological Chemistry.

[14]  Christopher P. Davis,et al.  Cdc 73 Subunit of Paf 1 Complex Contains C-terminal Ras-like Domain That Promotes Association of Paf 1 Complex with Chromatin * , 2012 .

[15]  O. Rozenblatt-Rosen,et al.  SHP2 tyrosine phosphatase converts parafibromin/Cdc73 from a tumor suppressor to an oncogenic driver. , 2011, Molecular cell.

[16]  Michael Head,et al.  The hub of the matter. , 2010, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[17]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[18]  R. Thakker,et al.  Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism‐jaw tumor syndrome (HPT‐JT) and parathyroid tumors , 2010, Human mutation.

[19]  R. Roeder,et al.  The Human PAF1 Complex Acts in Chromatin Transcription Elongation Both Independently and Cooperatively with SII/TFIIS , 2010, Cell.

[20]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[21]  E. Cho,et al.  The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression , 2009, Nucleic acids research.

[22]  R. Thakker,et al.  Parafibromin – functional insights , 2009, Journal of internal medicine.

[23]  R. Roeder,et al.  Direct Bre1-Paf1 Complex Interactions and RING Finger-independent Bre1-Rad6 Interactions Mediate Histone H2B Ubiquitylation in Yeast* , 2009, The Journal of Biological Chemistry.

[24]  K. Basler,et al.  The role of Parafibromin/Hyrax as a nuclear Gli/Ci-interacting protein in Hedgehog target gene control , 2009, Mechanisms of Development.

[25]  T. Pederson,et al.  In search of nonribosomal nucleolar protein function and regulation , 2009, The Journal of cell biology.

[26]  J. Hiscox,et al.  Nucleolar targeting: the hub of the matter , 2009, EMBO reports.

[27]  W. Simonds,et al.  The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene , 2008, Proceedings of the National Academy of Sciences.

[28]  A. Shilatifard,et al.  Parafibromin, a Component of the Human PAF Complex, Regulates Growth Factors and Is Required for Embryonic Development and Survival in Adult Mice , 2008, Molecular and Cellular Biology.

[29]  D. Marsh,et al.  Nucleolar localization of parafibromin is mediated by three nucleolar localization signals , 2007, FEBS letters.

[30]  K. Yoshimoto,et al.  Parafibromin tumor suppressor enhances cell growth in the cells expressing SV40 large T antigen , 2007, Oncogene.

[31]  C. Marcocci,et al.  Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation. , 2007, Endocrine-related cancer.

[32]  H. Moch,et al.  Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene , 2007, Oncogene.

[33]  N. Loh,et al.  Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal , 2007, Oncogene.

[34]  D. Marsh,et al.  Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin , 2007, Oncogene.

[35]  Wladek Minor,et al.  HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes. , 2006, Acta crystallographica. Section D, Biological crystallography.

[36]  D. Kimelman Faculty Opinions recommendation of Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo. , 2006 .

[37]  K. Basler,et al.  Parafibromin/Hyrax Activates Wnt/Wg Target Gene Transcription by Direct Association with β-catenin/Armadillo , 2006, Cell.

[38]  Zbyszek Otwinowski,et al.  The integration of data reduction and structure solution - from diffraction images to an initial model in minutes , 2005 .

[39]  W. Simonds,et al.  Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression , 2005, Oncogene.

[40]  O. Rozenblatt-Rosen,et al.  The Parafibromin Tumor Suppressor Protein Is Part of a Human Paf1 Complex , 2005, Molecular and Cellular Biology.

[41]  Mark Johnston,et al.  The Paf1 Complex Is Essential for Histone Monoubiquitination by the Rad6-Bre1 Complex, Which Signals for Histone Methylation by COMPASS and Dot1p* , 2003, Journal of Biological Chemistry.

[42]  J. Carpten,et al.  HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome , 2002, Nature Genetics.

[43]  C. Larsson,et al.  Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. , 1996, The Journal of clinical endocrinology and metabolism.

[44]  P. Wade,et al.  Paf1p, an RNA polymerase II-associated factor in Saccharomyces cerevisiae, may have both positive and negative roles in transcription , 1996, Molecular and cellular biology.

[45]  S. Chew,et al.  Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. , 1995, American journal of human genetics.

[46]  A T Brünger,et al.  Helix packing in proteins: Prediction and energetic analysis of dimeric, trimeric, and tetrameric GCN4 coiled coil structures , 1994, Proteins.

[47]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.